1. Home
  2. COLM vs VRDN Comparison

COLM vs VRDN Comparison

Compare COLM & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Columbia Sportswear Company

COLM

Columbia Sportswear Company

HOLD

Current Price

$54.02

Market Cap

2.9B

ML Signal

HOLD

Logo Viridian Therapeutics Inc.

VRDN

Viridian Therapeutics Inc.

HOLD

Current Price

$33.64

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLM
VRDN
Founded
1938
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
3.2B
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
COLM
VRDN
Price
$54.02
$33.64
Analyst Decision
Hold
Strong Buy
Analyst Count
8
13
Target Price
$58.00
$41.17
AVG Volume (30 Days)
534.5K
1.4M
Earning Date
02-03-2026
02-26-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
3.37
N/A
Revenue
$3,423,711,000.00
$70,789,000.00
Revenue This Year
$1.70
$26,257.62
Revenue Next Year
$1.78
$4.54
P/E Ratio
$16.00
N/A
Revenue Growth
2.75
23340.07
52 Week Low
$47.47
$9.90
52 Week High
$92.88
$34.29

Technical Indicators

Market Signals
Indicator
COLM
VRDN
Relative Strength Index (RSI) 48.33 61.19
Support Level $52.07 $31.26
Resistance Level $55.15 $34.29
Average True Range (ATR) 1.58 1.30
MACD -0.09 0.09
Stochastic Oscillator 34.52 84.28

Price Performance

Historical Comparison
COLM
VRDN

About COLM Columbia Sportswear Company

Columbia Sportswear Co makes outdoor and active-lifestyle apparel, footwear, equipment, and accessories that it sells under four primary brands: Columbia, Sorel, Mountain Hardwear, and prAna. The majority of sales are in the United States, but the company also has remarkable sales in its three other geographic segments: Latin American and Asia-Pacific; Europe, Middle East, and Africa; and Canada. The majority of sales are through wholesale channels, including sporting goods and department stores, but the company also operates its own branded stores in each of its geographic segments. Columbia sources products from around the world and uses contract manufacturers outside the United States, predominantly in Asia to manufacture its various products.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).

Share on Social Networks: